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Abstract 
Septic arthritis is a very common orthopaedic emergency. Surgical debridement and empiric 
antibiotic cover together make up the vital initial management of septic arthritis. Empiric 
antibiotic cover is determined using the most prevalent bacteria in a specific clinical setting given 
the patient profile. The purpose of the study was to determine the microbiological spectrum that 
is responsible for septic arthritis at our centre and the antibiotic sensitivity thereof. This 
retrospective study included 82 patients who were admitted with a diagnosis of septic arthritis. 
The microbiological and biochemical results of these patients were retrospectively reviewed. All 
patients older than 18 years with a clinical diagnosis of septic arthritis who were taken to theatre 
for an arthrotomy were included in the study. Gram positive species were more common 
compared to gram negative species at 51% and 40% respectively, with Staphylococcus aureus 
being the most common gram positive and Pseudomonas species the most common gram-
negative pathogen. Antibiotic resistant bacteria like Methicillin-resistant Staphylococcus aureus 
and Acinetobacter baumannii were each found to be responsible in 7% of cases. The use of 
Cloxacillin as empiric antibiotic cover was effective in only 30% of cases. To increase cover the 
use of vancomycin as empiric antibiotic should be considered, as vancomycin had better empiric 
cover at 54% against all isolates. In cases of suspected Streptococcal infections, Penicillin or 
Erythromycin should be considered.  Gram negative species are rarely isolated as offending 
organisms in septic arthritis, when found these infections can be difficult to treat. According to 
our study Amikacin and Gentamycin should be considered in all cases of suspected gram 
negative septic arthritis. Mycobacterium tuberculosis complex should be considered in patients at 
risk as the antibiotic treatment used is unique and for a relatively extended period compared to 
other bacteria. Regular microbiological profiling of bacteria in each centre is important in 
determining the appropriate empiric antibiotic treatment for septic arthritis. 
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Chapter 1 - Introduction and Literature Review 
Septic arthritis is a term commonly used to describe acute joint infection caused by bacterial 
micro-organism, even though other micro-organisms like fungi, viruses and parasites can also 
cause septic arthritis (1). Presence of micro-organisms in the joint commonly presents as an acute 
mono-arthritis. These microbial joint infections usually respond well to early, adequate and 
appropriate treatment. This consists of an initial surgical drainage and debridement and empiric 
intravenous antibiotics. Inadequate treatment results in joint destruction from the inflammatory 
process and the microbiological cause. The consequence of which can be lifelong disability, and 
in the case of severe septicaemia, even death. This usually occurs in patients with underlying 
comorbidities, rheumatoid arthritis and the elderly (2).  
The presence of a hot, swollen painful joint usually raises the suspicion of a septic arthritis. These 
clinical signs and symptoms however have long lists of differential diagnosis, in one study Non-
gonococcal arthritis had a prevalence of only 27% amongst patients who presented to a casualty 
with such symptoms. Other conditions that should be considered as differential diagnosis are 
included in Table 1.1 below (3, 4). Incidence of septic arthritis in the general population is 
estimated at 2 − 10 per 100 000 patient years. Patients at high risk of developing septic arthritis 
(e.g. rheumatoid arthritis patients) have incidence as high as 70 cases per 100 000 patient years 
(5). Conditions such as underlying joint pathology, a background of a systemic disease and 
compromised immune status, predispose patients to higher risks of developing septic arthritis.  
The risk factors for septic arthritis are listed in page 3 (6). Septic arthritis can affect any age 
group but it is common at extremes of ages,  and the incidence in male and female patients is 
equal (7). 
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Table 1.1 Differential diagnosis of septic arthritis 
Infective Septic arthritis (bacterial, fungal, parasitic) 
Osteoarticular Tuberculosis 
Cellulitis  
Lyme disease 
Degenerative  Osteoarthritis 
Inflammatory Psoriatic arthritis 
Rheumatoid arthritis 
Crystal deposition disorders Gout 
Pseudogout  
Other causes Haemathrosis 
Trauma 
Bursitis 
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List of Risk Factors for developing septic arthritis: 
 
• Degenerative joint disease 
• Rheumatoid arthritis 
• Corticosteroid therapy 
• Diabetes mellitus 
• Leukemia 
• Cirrhosis 
• Granulomatous diseases 
• Cancer 
• Hypogammaglobulinemia 
• Intravenous substance abuse 
• Renal disease 
• Patients undergoing cytotoxic chemotherapy 
 
Patients usually present within two weeks of onset of symptoms, but an infection caused by a low 
virulence organism will have a comparatively delayed presentation (8). Patients can present with 
any or a combination of the cardinal signs of inflammation. These include acute joint pain, 
swelling around the joint, warmth, erythema, decreased range of motion, fever and generalised 
malaise (6). Systemic constitutional symptoms such as fever, chills, or rigors are however not 
always present, with sensitivities of 57%, 27% and 19%, respectively for septic arthritis (9). This 
sometimes makes a clinical diagnosis difficult, and a high index of suspicion is needed.  
 
Any joint can be affected, with the knee joint (48%) being the most prone to infection (10). 
Lower limb joints are more vulnerable compared to upper limb and axial skeleton joints (see 
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Table 1.2 below) (11). Trauma, contiguous spread of infection and diabetes,  predisposes patients 
to unusual presentation of septic arthritis, where small joints of hand and feet can be affected 
(12). Involvement of the axial skeleton joints such as the spine, sternoclavicular joint and the 
pubic symphysis have been reported in patients with history of intravenous drug abuse and 
patients with indwelling catheters (13). Septic arthritis commonly affects a single joint, but oligo-
articular or even poly-articular infections do not exclude the diagnosis of septic arthritis, as up to 
22% of septic arthritis patients have multiple joint involvement (14).  
Table 1.2 Distribution Table of the affected joints 
 
 
 
 
Septic arthritis is mostly a clinical diagnosis, but adjuncts do aid in confirming diagnosis. This 
includes serum markers of inflammation and infection e.g. White Cell Count (WCC), Erythrocyte 
Sedimentation rate (ESR) and C-Reactive Protein (CRP). Amongst all these markers CRP was 
shown to be the most reliable compared to ESR and WCC  (12). In a retrospective study, 
significant increases of CRP up to 100 mg/L were shown to only slightly increase the likelihood 
of septic arthritis (15). Serum procalcitonin, a relatively newer marker of inflammation and 
infection was shown to have a predictive diagnostic sensitivity and specificity of 65% and 88% 
Affected Joint Percentage Distribution 
Knee 65% 
Hip 12% 
Shoulder 6% 
Elbow 6% 
Wrist 4% 
Ankle 4% 
Sternoclavicular 3% 
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respectively in patients with septic arthritis (16). In a study done by Weston et al. (1999) in the 
United Kingdom only 24% of patients with confirmed positive synovial cultures had positive 
bacterial identification in their blood cultures, and in 9% of the patients with a clinical diagnosis 
of septic arthritis a positive blood culture was the only source of bacterial identification (12). 
 
Synovial fluid microscopic and macroscopic analysis are useful tools in diagnosing joint sepsis 
and crystal induced arthropathies such as gout and pseudogout (17). Microscopic analysis should 
always be coupled with synovial fluid culture, as gram staining alone is only positive in 50% of 
the cases (12). Synovial WCC of greater than 50 000 cells/mm3 is suggestive of septic arthritis, 
however lower levels do not exclude the diagnosis of septic arthritis (9). Given the 
pathophysiology of septic arthritis these biochemical derangements in synovial fluid tests are 
expected, decreased synovial fluid glucose level, raised lactate dehydrogenase and raised protein 
levels, but however, low sensitivity and specificity limit the usefulness of these tests (9). There is 
currently not enough clinical evidence to support the use of blood-culture bottles over 
conventional agar culture in an attempt to increase diagnostic yield (18). Polymerase chain 
reaction (PCR), a process of identification and amplification of genetic material has recently 
found use in confirming diagnosis of joint infections where antibiotics are administered before 
arthrotomy or culture results are negative in clinically confirmed cases of septic arthritis (19). 
Conventional radiographs done in 2 orthogonal planes are used in conjunction with clinical 
examination  as the first form of radiological investigation in septic arthritis, but radiographs are 
less effective in early joint infection as they may show no changes except soft tissue swelling 
(20). Late presentation of septic arthritis may present with Phemister’s triad on radiographs. 
These includes joint space narrowing, marginal subchondral bone erosions, and peri-articular 
osteopenia (20).  Ultrasound has been used extensively in the diagnosis of musculoskeletal 
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infections. Absence of joint effusion on ultrasound has been shown to have a high negative 
predictive value for septic arthritis. Although the presence of an effusion is not specific for septic 
arthritis (21). Magnetic Resonance Imaging (MRI) may be useful in cases where joints are deep 
seated and diagnosis is unclear. MRI may show complex joint effusions with changes in signal 
intensity in both T1W and T2W images. Other associated MRI changes include synovial 
thickening, peri-synovial edema and capsular pouching. The absence of effusion on MRI does not 
exclude the diagnosis of septic arthritis (22). 
Septic arthritis shows a typical increased radionuclide uptake in all 3 phases (the perfusion, blood 
pool, and osseous phase) of  99m Tc-diphosphonates scintigraphy scan, the image is in keeping 
with the hyperemic synovial vessels. Radionuclide imaging can be useful in early septic arthritis 
where radiological changes are not yet present (23). 
Septic arthritis is triggered when bacteria are introduced into the sterile joint and synovial fluid. 
Hematogenous spread of bacteria following a period of bacteremia is the most common route 
leading to septic arthritis (6). Less common routes by which bacteria can be introduced into joints 
include joint aspiration procedures, penetrating injuries and blunt trauma to the joint without a 
break in skin continuity (24). Synovium that lines joints is well vascularized but lacks the 
protective basement membrane, this pre-disposes joints to hematogenous bacterial seeding (25).  
Gram positive bacteria are responsible for the majority of septic arthritis cases, this is attributed 
to gram positive species’ abilities to bind with the host’s connective tissue and extracellular 
matrix proteins (7). S. aureus’ ability to be the most common cause of septic arthritis is enhanced 
by its microbiological characteristics (7). Specific genes that code for proteins which are used as 
receptors have been identified in S. aureus species responsible for the destructive septic arthritis. 
These features coupled with the ability of S. aureus to survive inside neutrophils and other cells 
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of inflammation makes it a difficult bacterial infection to treat (26). Introduction of bacteria into a 
patient’s joint leads to an inflammatory response. Bacterial components such as the cell wall, 
adhesins, toxins and enzymes trigger this response (27). Introduction of the foreign material into 
the joint triggers the host immune response, but it is the host’s response which causes most of the 
damage associated with joint infection (28). The body responds to the presence of bacteria and 
bacterial components with hyperplasia of synovial lining cells, migration of inflammatory cells 
into synovium and synovial fluid leading to the typical purulent synovial fluid of septic arthritis 
(29). Inflammatory cells release proteases, cytokines, interleukins and tumor necrosis factor that 
directly or indirectly cause cartilage destruction and inhibition of new cartilage formation (6). 
Joint infection and the inflammatory process associated with it, leads to an increase in joint fluid 
causing increased intra-articular pressure hampering blood flow to the joint and peri-articular 
structures. This leads to cartilage and synovium ischemia (25).  
Generally, any bacteria can cause septic arthritis. Table 1.3 shows the most common micro-
organisms isolated in a study conducted at Steve Biko Academic Hospital in Pretoria, South 
Africa. The study group included 125 patients with the diagnosis of septic arthritis (30). 
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Table 1.3 Organisms isolated in 125 cases of septic arthritis in adult patients 
 
Organisms No. of Isolates 
Gram positive 42 
Sthaphylococcus aureus 20 
Coagulase negative staphylococcus 11 
Streptococcus pneumniae 1 
Alpha-haemolytic streptococcus 5 
Beta-haemolytic streptococcus 5 
Gram negatives 29 
Acinetobacter baumannii 4 
Klebsiella pneumoniae 4 
Klebsiella oxytoca 2 
Enterobacter spp 5 
Eschericiae coli 4 
Serratia marscence 1 
Proteus mirabilis 1 
Proteus vulgaris 1 
Pseudomonas aeruginosa 6 
Pseudomonas stutzeri 1 
Other 9 
 
  
 
Both local and international studies agree that S. aureus is the most prominent pathogen causing 
septic arthritis with incidences as high as 44% (10, 31, 32). The proportion of cases caused by S. 
aureus in rheumatoid arthritis patients is even higher reported at 75% (33). Streptococcus species 
are the second most common pathogen causing septic arthritis (approx. 28%) with S. pyogenes 
being the most common of the Streptococcus spp. (6, 32). MRSA is a difficult bacteria to treat and 
accounts for 5.00 – 25% of bacterial septic arthritis cases (34). Gram negative bacilli joint 
infection occurs in 14 – 19% of all septic arthritis cases and is commonly associated with 
conditions such as urinary tract infections, intravenous drug abuse and skin infections (6, 35).  P. 
aeruginosa and E. coli are the two most common gram negative species (35, 36). Systemic 
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micro-biological infections like diarrhea can pre-dispose patients to uncommon micro-organism 
septic arthritis such as Shigella spp., Salmonella spp., Campylobacter spp. or Yersinia spp. (37). 
Gonococcal septic arthritis is a rare disease except in the United States where the incidence of 
Gonococcal infections in general was shown to have increased between 1997 – 1999 by 9% to a 
level of 133, 2 cases per 100 000 per year (38). Septic arthritis caused by multiple bacteria occurs 
in approximately 10% of cases (6). Literature is generally in agreement that the most common 
pathogens causing septic arthritis being S. aureus and Streptococcus spp., but there are multiple 
case reports of rare pathogens e.g. Corynebacterium striatum causing shoulder septic arthritis; 
Fusobacterium necrophorum causing septic arthritis in patients with Lemierre syndrome which 
classically is described as pharyngitis, septicemia and internal jugular vein thrombosis (39, 40). A 
very rare cause of septic arthritis caused by Sphingomonas paucimobilis has been reported in an 
immuno-competent patient. This bacterium is found in soil, drinking water and even in hospital 
equipment such as nebulizers and ventilators and has been shown to have high antibiotic 
resistance (41). 
Treatment 
Urgent removal of purulent material from the joint and empiric antibiotic treatment is the 
mainstay of treatment in septic arthritis. Septic joints can be drained either by closed means using 
needle decompression, or surgically by means of arthrotomy or arthroscopy. There are no studies 
that show the effectiveness of a specific method of joint drainage over another (42-45).  If left 
untreated septic arthritis causes cartilage destruction, joint space narrowing, subchondral bone 
loss, peri-articular ligament disruption and occasionally sinus tract formation (46). Septic arthritis 
is a medical emergency. Inadequate or inappropriate treatment may lead to irreversible joint 
damage and thus substantial morbidity and mortality (47-49). Reported septic arthritis mortality 
rates range from 4 to 42%, with poly-articular septic arthritis having mortality rate values as high 
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as 50% (31, 47, 50). In the acute phase of the infection, the use of splints to prevent flexion 
contracture deformity is critical as patients prefer to flex their joints. This flexed position of 
comfort increases joint space, therefore, reducing intra-articular pressure and pain (51). 
Initial antibiotic of choice in treatment of septic arthritis is empiric, based on the most common 
pathogens in that community and according to patient specific risk factors. That particular choice 
is later modified guided by microbiological gram stain and culture results (49). The British 
society of rheumatology guidelines for the management of the hot swollen joint in adults suggests 
intravenous treatment for two weeks then oral treatment for four weeks (18). 
A 10-year review of empiric antibiotic use in treatment of septic arthritis done in Switzerland 
showed that Amoxicillin/Clavulanate or Cefuroxime would have been an appropriate antibiotic in 
85% of large joints and only 75% of small joints infections (52). In other studies, the clinical 
importance of community acquired MRSA in causing septic arthritis was highlighted and that 
empiric antibiotic cover aimed at MRSA should be considered (53). In the Pretoria study, S. 
aureus was isolated in 25% of the cases and the use of Cloxacillin as empiric antibiotic treatment 
was only effective in 32% of the cases (30).  
The most common pathogen causing septic arthritis differs from one geographic region to another 
and varies per patient’s specific risk factor profiles; hence the need for each centre to regularly 
assess common pathogens causing septic arthritis and their antibiotic sensitivities cannot be over-
emphasised.  
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1.1 Research Aim and Objectives 
Since the management of septic arthritis includes empiric antibiotic treatment that is later 
changed according to microbiological results, it is important for each centre to determine the 
most common pathogens and their antibiotic sensitivities. This will better guide treatment 
protocols with regards to the use of empiric antibiotics. The aim of this study was to determine 
common pathogens at Chris Hani Baragwanath Academic Hospital. The research specific 
objectives were as follows:  
1. To document all pathogens found in cases of septic arthritis 
2. To determine antibiotic sensitivity of the pathogens 
3. To make recommendations towards empiric antibiotic treatment of septic arthritis in 
adult patients  
12 
 
Chapter 2 - Methodology  
The study was an observational retrospective analysis of results in all patients who had a clinical 
diagnosis of septic arthritis that and were taken to theatre for an arthrotomy. The study was 
conducted at Chris Hani Baragwanath Academic Hospital, over a period of four years (09 April 
2010 to 28 December 2014). 
Data collected included admission white cell count, ESR, CRP and post-operative synovial fluid 
microbiological analysis results 
 
2.1 Study population  
The study population included all adult patients who were admitted with a diagnosis of septic 
arthritis and taken to theatre for an arthrotomy between 09 April 2010 and 28 December 2014. 
Chris Hani Baragwanath Academic Hospital is the third largest hospital in the world with 3200 
beds. The hospital is in the Soweto area of Johannesburg, South Africa. It is one of the 40 
Gauteng provincial hospitals, is financed and run by the Gauteng Provincial Health Authorities. It 
is a teaching hospital for the University of the Witwatersrand Medical School. It serves the 
community of Soweto which has a population of approximately 1.3 Million per census 2011 and 
is a referral hospital for other areas of South Africa and Southern Africa (54,55) .  
2.2 Inclusion criteria  
The inclusion criteria for this study included:  
• All patients who were admitted with a clinical diagnosis of septic arthritis taken to theatre 
for an arthrotomy 
• Patients 18 years and older  
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2.3 Exclusion criteria  
The exclusion criteria for this study included: 
• All paediatric patients (younger than 18 years) 
• Patients with joint replacements  
• All patients found in theatre register that had no records and results available at 
the laboratory database 
2.4 Data collection procedure 
All patients with a clinical diagnosis of septic arthritis are exclusively managed by the 
Orthopaedic department. Septic arthritis is mainly a clinical diagnosis. When patients are 
diagnosed, blood samples are taken for serum WCC, ESR and CRP which are used as adjuncts in 
diagnosis as well as to serially monitor response to treatment. All Patients with a clinical 
diagnosis of septic arthritis are then taken to theatre for a formal joint arthrotomy and 
debridement. Arthroscopy and needle decompression as methods of either diagnosis or treatment 
are not used in our centre. In theatre, the surgeon collects joint fluid and synovium which is sent 
to the Microbiology laboratory for gram staining, culture and antibiotic sensitivity tests. Post 
initial arthrotomy patients are placed on empiric Cloxacillin treatment while awaiting 
microbiology results to guide further antibiotic choice. 
Theatre registries were used to find all patients who had surgical debridement of their joints. 
Patients’ names and Hospital file numbers were used to request blood and microscopy results 
from the National Health Laboratory Services (NHLS). Results received from the laboratory were 
compared to initial theatre registries list sent and all patients not appearing on the list of results 
received from the laboratory were excluded from the study. A data collection sheet was used that 
did not include any patient identification data (see Appendix C). 
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2.5 Data analysis  
Measurement of central tendencies were used to analyse the frequency, mean and standard 
deviation of the demographic characteristics, WCC, CRP, ESR as well as the type of bacteria 
cultured from the laboratory and their sensitivities and resistance to antibiotics usually used in 
treating septic arthritis. The level of significance was measured by using the Chi-square and the 
Fischer’s exact test to determine the association between the sensitivity and resistance of specific 
antibiotics used on specific bacteria. One-way ANOVA was used to determine the significance 
difference between the bacteria and the age of the patients. All data analysis was carried out using 
the IBM SPSS 23.0 ®. 
 
2.6 Ethics  
The study was approved unconditionally by the Human Research Ethics Committee (Medical), 
Faculty of Health Services, University of the Witwatersrand (Clearance certificate no. M140975, 
Appendix A). 
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Chapter 3 - Results 
3.1 Results 
3.1.1 Demographics 
The theatre registries had a total of 136 patients that had arthrotomies of the joints; of those 
patients submitted to the laboratory only 82 patients had records and results according to 
laboratory data. A total of 54 patients were excluded due to unavailability of results during that 
four-year period between April 2010 and December 2014. Results were not available for 54 
patients, and these were excluded from the study. Most patients (43%) were between the ages 34 
and 49 years. Figure 3.1 below shows a graphical representation of the age distribution of the 
patients. 
 
 
 
Figure 3.1 A graphical illustration of the age distribution of the 82 patients categorised between 
8-year periods 
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The age groups from 26 years to 49 years accounted for 61% of the patients in our study. The age 
range of the patients in this study was 18 – 68 years with a mean age of 44.14 ± 12.56 years. 
3.1.2 Bacteria species recorded from the laboratory 
The laboratory had recorded a total of 203 laboratory results belonging to 82 patients as identified 
by their hospital numbers, 28 different types of bacteria were identified. The different bacteria 
isolated were then divided into four broad groups based on their gram staining characteristics, i.e. 
gram positive, gram negative and mycobacterium species. Figure 3.2 graphically shows the 
results of gram staining. There is a predominance of gram positive 55% (n = 112) over gram 
negative 40% (n = 81) species and Mycobacterium species at 5% (n = 10). 
  
 
Figure 3.2 A graphical representation of the gram staining results 
 
Further analysis of the culture results revealed a total number of 28 different types of bacteria and 
the frequency of the specific isolated bacteria is outlined in Table 3.1 below. Of the 82 patients 
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taken to theatre for arthrotomies, 45 patients (55%) had multiple arthrotomies. Twenty-nine of 
those 45 patients (64%) with multiple arthrotomies had a change in the bacteria isolated from the 
index and a subsequent arthrotomy, which might signify hospital acquired infections. Our results 
had no cases where no growth was reported and no fungal infections were reported. 
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Table 3.1 Distribution table of bacterial isolates from the laboratory culture results 
Bacteria name (N = 203) Frequency (n) % distribution of bacteria 
Staphylococcus aureus 58 29% 
Pseudomonas aeruginosa 18 9% 
Escherichia coli 16 8% 
Acinetobacter baumannii 15 7% 
Methicillin-Resistant Staphylococcus aureus 14 7% 
Mycobacterium tuberculosis complex 10 5% 
Proteus mirabilis 10 5% 
Coagulase negative staphylococcus 6 3% 
Enterococcus faecium 6 3% 
Klebsiella species 6 3% 
Enterococcus faecalis 5 2% 
Streptococcus agalactiae 5 2% 
Streptococcus pyogenes 5 2% 
Enterobacter species 4 2% 
Enterobacter cloacae 3 1% 
Klebsiella pneumoniae 3 1% 
Streptococcus pneumoniae 3 1% 
Viridans streptococcus  3 1% 
Citrobacter koseri 2 1% 
Staphylococcus epidermidis 2 1% 
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Table 3.1 Continues - Distribution table of bacterial isolates from the laboratory culture results 
Bacteria name (N = 203) Frequency (n) % distribution of bacteria 
Streptococcus group B 2 1% 
Enterobacter aerogenes 1 0.5% 
Haemophilus parainfluenzae 1 0.5% 
Klebsiella oxytoca 1 0.5% 
Serratia marcescens 1 0.5% 
Staphylococcus haemolyticus 1 0.5% 
Streptococcus anginosus 1 0.5% 
Streptococcus species 1 0.5% 
 
S. aureus accounted for 29% of the total bacteria isolated from laboratory records. Also, P. 
aeroginosa, E coli and A. baumannii account for 9%, 8% and 7% respectively of the total 
bacteria isolated.  
The isolated bacteria were further grouped into species and the results showed that the 
Staphylococcus spp. (combined) accounted for 40% of the total bacteria followed by the 
Streptococcus spp. at 10%. Figure 3.3 below shows the distribution of the bacteria species 
identified from the laboratory report.  
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Figure 3.3 A graphical representation of the various bacteria species isolated from the laboratory 
(with all Staphylococcus spp. and all Streptococcus spp. combined) 
 
Amongst gram positive bacteria S. aureus (52%) and MRSA (13%) were the most identified, 
while P. aeruginosa (22%) and E. coli (20%) were the most identified gram-negative bacteria. 
Tables 3.2 and 3.3 below show the distribution of gram-positive and gram-negative bacteria 
respectively.  
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Table 3.2 Distribution table of the gram-positive bacterial isolates  
Gram Positive Bacteria (N = 112) Frequency (n) % distribution  
Staphylococcus aureus  58 5% 
Methicillin-Resistant Staphylococcus aureus  14 13% 
Coagulase negative staphylococcus 6 5% 
Enterococcus faecium 6 5% 
Enterococcus faecalis 5 4% 
Streptococcus agalactiae 5 4% 
Streptococcus pyogenes 5 4% 
Streptococcus pneumoniae 3 3% 
Viridans streptococcus  3 3% 
Staphylococcus epidermidis 2 2% 
Streptococcus group B  2 2% 
Staphylococcus haemolyticus 1 1% 
Streptococcus anginosus 1 1% 
Streptococcus species  1 1% 
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 Table 3.3 Distribution table of the gram-negative bacterial isolates 
 
  
Gram negative bacteria (N = 81) Frequency (n) % distribution 
Pseudomonas aeruginosa 18 22% 
Escherichia coli 16 20% 
Acinetobactre baumannii 15 19% 
Proteus mirabilis 10 12% 
Klebsiella species 6 7% 
Enterobacter species 4 5% 
Enterobacter cloacae 3 4% 
Klebsiella pneumonia 3 4% 
Citrobacter koseri 2 3% 
Enterobacter aerogenes 1 1% 
Haemophilus parainfluenzae 1 1% 
Klebsiella oxytoca 1 1% 
Serratia marcescens 1 1% 
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3.1.3 Antibiotic sensitivity and resistance 
3.1.3.1 Staphylococcus species 
Staphylococcus species was the most common bacteria identified. From the records and as shown 
in Figure 3.4 below, Staphylococcus sp. had 100% sensitivity to Fusidic acid, Linezoloid and 
Vancomycin. The Staphylococcus sp. showed the most resistance towards Penicillin at 90%. 
Staphylococcus species had a total of 75% sensitivity to cloxacillin. 
 
Figure 3.4 A graphical illustration of the sensitivity and resistance of the combined 
Staphylococcus species to antibiotics 
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3.1.3.2 S. aureus and MRSA 
The results of the sensitivity and resistance of antibiotics to the two most common 
Staphylococcus species, S. aureus and MRSA, showed that S. aureus was sensitive to Cloxacillin 
in (95%) cases. MRSA was reported in 14 cases and as expected there was 100% resistance to 
cloxacillin. Both MRSA and S. aureus showed high sensitivity to Linezoloid, Fusidic acid and 
Vancomycin as shown in Table 3.4 below. S. Aureus had a very high resistance to Penicillin 
(89%) and MRSA showed absolute resistance to Penicillin. Cloxacillin was appropriate as 
treatment in 75% of all Staphylococcus spp. cases which translates to only 30% cover of all the 
bacteria involved in this study (see Figure 3.4). 
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Table 3.4 Specific sensitivity and resistance of antibiotic to S. Aureus and MRSA 
 Staphylococcus aureus (n) MRSA (n) 
Antibiotic Resistance Sensitivity Resistance Sensitivity 
Amikacin 0 27 6 5 
Chloramphenicol 3 54 6 8 
Ciprofloxacin 4 53 14 0 
Gentamicin 7 51 13 1 
Clindamycin 0 57 6 8 
Erythromycin 7 51 14 0 
Fusidic acid 0 58 0 14 
Linezoloid 0 58 0 14 
Cloxacilin 3 55 14 0 
Penicillin 51 6 14 0 
Rifampicin 3 55 10 4 
Trimethoprim/sulfamethoxazole 6 23 - - 
Quinupristin/Dalfopristin 0 28 0 14 
Vancomycin 0 58 0 12 
 
The Chi-square results used to determine the level of association between resistance and 
sensitivity of specific antibiotic to S. aureus showed that there was a significant difference in all 
the antibiotics used for S. aureus. This bacterium, S. aureus showed a significant sensitivity to all 
other antibiotics used except for Penicillin where a significant resistance was noted (p < 0.001).   
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MRSA showed a significant level of resistance to Gentamicin (p < 0.001). Table 3.5 below 
outlines the Chi-square results of the significant difference between the sensitivity and resistance 
of bacteria to antibiotics tested for S. aureus and MRSA.  
Table 3.5 An association between antibiotic sensitivity and resistance of S. aureus and MRSA 
 Staphylococcus MRSA 
Antibiotic X2 p-value X2 p-value 
Amikacin - - 0.09 0.76 
Clindamycin - - 0.29 0.59 
Gentamicin 33.38 < 0.01 10.29 < 0.01 
Rifampicin 46.62 < 0.01 2.57 0.11 
Chloramphenicol 45.63 < 0.01 0.29 0.59 
Ciprofloxacin 42.12 < 0.01 - - 
Erythromycin 33.38 < 0.01 - - 
Cloxacilin 46.62 < 0.01 - - 
Penicillin 35.53 < 0.01 - - 
Trimethoprim/Sul
famethoxazole 
9.97 < 0.01 - - 
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3.1.3.3 Streptococcus species 
The Streptococcus sp. is the second most reported bacteria in this study and as shown in Figure 
3.5 below. The Streptococcus sp. showed no resistance to both Vancomycin (100%) and 
Linezolid (100%). The highest resistance recorded for Streptococcus sp. was to Tetracycline at 
33%. 
 
Figure 3.5 A graphical illustration of the sensitivity and resistance of Streptococcus species to 
antibiotics 
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3.1.3.4. Pseudomonas species 
The Pseudomonas sp. was the most common group of gram negative bacteria and they showed 
high sensitivity to Amikacin (100%) and between 93 and 94% sensitivity to Ciprofloxacillin, 
Imipenem, Cefepime, Cefotaxime, Tobramycin, Meropenem and Gentamicin. Pseudomonas sp. 
showed 100% resistance to Tetracycline and Trimethoprim-sulfamethoxazole as shown in Figure 
3.6 below. 
 
  
Figure 3.6 A graphical illustration of the sensitivity and resistance of Pseudomonas species to 
antibiotics 
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3.1.3.5. Escherichia coli 
The E. coli bacteria were most sensitive to Piperacilin-Tazobactam (94%), Impenem (94%) and 
Meropenem (94%). The bacterium E. Coli was most resistant to Ampicillin (73%) as illustrated 
in Figure 3.7 below. 
 
Figure 3.7 A graphical illustration of the sensitivity and resistance of E. Coli bacteria to 
antibiotics 
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3.1.3.6. A. Baumannii 
The bacteria A. baumannii were most sensitive to Tobramycin (73%), Gentamicin (67%) and 
Amikacin (67%). The bacteria were 100% resistant to Tetracycline, Trimethoprim- 
sulfamethoxazole and Nalixidic acid. Also, the bacteria showed high resistance to Piperacilin/ 
Tazobactam (92%), Impenem (92%) and Meropenem (80%) as illustrated in Figure 3.8 below. 
 
 
Figure 3.8 A graphical illustration of the sensitivity and resistance of A. Baumannii to antibiotics 
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3.1.3.7. Mycobacterium tuberculosis 
Rifampicin was the only antibiotic used to test resistance and sensitivity of MTB positive cultures 
found in this study, 63% cultures were sensitive to the antibiotic as shown in Figure 3.9 below. 
 
 
Figure 3.9 A graphical illustration of the sensitivity and resistance of Mycobacterium 
tuberculosis species to antibiotics  
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3.2 Most effective antibiotic used against gram positive and gram-negative bacteria 
The cultured bacteria were grouped into gram positive and gram-negative bacteria according to 
common microbiological characteristics. Figures 3.10 and 3.11 below demonstrate frequency of 
sensitivities and resistance that each antibiotic had against the group which it was tested on. 
 
Figure 3.10 A graphical representation of sensitivity and resistance of gram positive bacteria to 
antibiotics 
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Figure 3.11 A graphical representation of sensitivity and resistance of gram negative bacteria to 
antibiotics 
 
The above Figures 3.10 and 3.11 respectively showed that Linezolid (97) and Vancomycin (97) 
were the most effective antibiotic for gram positive bacteria while Meropenem (67), Gentamicin 
(58), Tobramycin (58) and Ceftazidime (55) were effective for gram negative bacteria.  
3.3. Laboratory results 
The percentage of cases with reported WCC, CRP and ESR were 19%, 14% and 8% respectively. 
ESR a marker of inflammation is termed normal if the rate is between 0 − 10mm/hr. The ranges 
of ESR values recorded in this study are outlined in Table 3.6 below. 
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Table 3.6 The ranges of Erythrocyte sedimentation rate 
ESR value (mm/hr) Number of 
cases 
Percentage 
0 − 10 1 3% 
11 − 100 14 42% 
>100 18 55% 
Total  33 100% 
 
CRP as another marker of inflammation is reported as normal if found to be less than 10mg/L, 
patterns in my study are demonstrated in Table 3.7 below.  
Table 3.7 C reactive protein values 
CRP level (mg/L) Number of cases Percentage 
< 10 1 3% 
10 − 50 0 0% 
51 − 200 18 51% 
> 200 16 46% 
Total  35 100% 
 
Raised WCC is often used as a marker of infection. Normally in absence of infection values 
range between (3.9 – 12.6) 109/L. Values of WCC in this study are demonstrated in Table 3.8 
below. 
 
35 
 
Table 3.8 White cell count values 
White cell count ranges          
( x 109/L) 
Frequency Percentage  
0 − 3.8 2 6% 
3.9 − 12.6 27 79% 
> 12.6 5 15% 
Total 34 100% 
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Chapter 4 – Discussions 
 
This is the first retrospective analysis to be done at our centre looking at bacteriology of septic 
arthritis where all surgical treatment of septic arthritis was done by the Orthopaedic department 
and all specimen and results processed at a single laboratory 
Demographics in this study showed that septic arthritis can affect any age group, the majority of 
our patients (61%) were in the middle-aged group of 26 − 49 years and the mean age being 44 
years ±12.56 years. This is in agreement with studies done elsewhere where their mean age 
among adult septic arthritis patients was 51 years ± 15years (56) .Septic arthritis in advanced age 
patients has been shown to have adverse outcomes, where death was reported in studies amongst  
these patients (57) . My study had 15% in the age group 58 years and older and in a similar study 
done in Nigeria (2013) up to 10% of their patients were above the age of 60 years. Given the 
figures for high complication rates in this age group, particular attention should be paid to these 
fragile patients (58). 
 
Gram positive species were the most common pathogens found in my study, this finding is 
common in most studies.(1, 49, 50). In one particular study the contribution of Staphylococcus 
and Streptococcus spp. was as high as 91% which is different from our finding of Streptococcus 
and Staphylococcus spp. contributing only 50% of all septic arthritis cases (50). 
The predominance of S. aureus as a causative agent in septic arthritis has been proven in 
literature; Ross et al. (2005) showed that S. aureus caused 44% of cases in their North American 
study which is in contradiction with our study where we found that only 29% of cases were 
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caused by S. aureus. Our study though, is more similar to a study done in Pretoria, where S. 
aureus caused 33% of all septic arthritis cases (7, 30). 
According to the 2006 guidelines on the management of the hot swollen joints in adults with 
septic arthritis from Britain, it was reported that in patients with no risk factors for atypical 
organisms, Fluxlocacillin could be used as the most appropriate antibiotic (59). Patient profiling 
per specific risk factors was not done in this study but Cloxacillin was appropriate as treatment in 
75% of all Staphylococcus spp. cases which translates to only 30% cover of all the bacteria 
involved in this study. The use of Vancomycin increases empiric antibiotic cover as it has 47% 
effectiveness against all isolates. In patients with suspected Streptococcus infection use of 
Penicillin and Erythromycin still provides reasonable cover with 89% and 89% effectiveness 
against Streptococcus spp. respectively. Newer drugs such as Linezolid with 100% effectiveness 
against gram positive species seem to be superior amongst all antibiotics 
 Resurgence of resistant strains in each centre warrants frequent assessment of common species 
and their antibiotic sensitivity. In a study done in Taiwan MRSA was found in up to 20% of cases 
of septic arthritis. In this study MRSA only caused 7% of septic arthritis cases, while in the 
Pretoria study showed that 11% were caused by MRSA (30, 61). MRSA in all the studies was 
shown to be exclusively sensitive to Linezolid and Vancomycin. Even though this study showed 
that MRSA, S. aureus and Streptococcus spp. all had 100% sensitivity to Vancomycin, the routine 
use of Vancomycin as a first line antibiotic is not advisable, as it may be associated with 
decreased clearance of the bacteria and other systemic side effects (61). 
 
 According to ministry in department of health the number of people living with HIV increased 
from 5.48 million to 6.19 million people in the period of 2011 to 2015 (62). This study was not 
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aimed at determining the impact of HIV on bacteriology of septic arthritis, but Zalavras et al. 
(2006) demonstrated that in patients with HIV infection and low CD4 count the most common 
pathogen was Oxacillin-resistant S. aureus (63). Further studies in our setting are required to 
understand the prevalence of HIV infection and incidence of resistant strains of S. aureus. 
Gram negative species account for up to 20% of micro-organisms causing septic arthritis and 
immune-compromised patients have higher incidence of gram negative micro-organisms, with E. 
coli and Pseudomonas spp. being the most common gram negative pathogens. This study showed 
that 40 % of cases were caused by gram negative bacteria and in agreement with other studies 
where Pseudomonas spp. and E.coli were the most common gram negative species (6).Gram 
negative septic arthritis although rare can be difficult to treat, requiring multiple surgical 
debridement and appropriate antibiotic treatment (64). Laboratory results showed that gram 
negative species best responded to Amikacin, Meropenem, and Gentamycin at 87%, 83% and 
72% respectively.  
Nosocomial infections have been on the rise over the years, infections with bacteria like A. 
baumannii are difficult to treat and have high mortality and morbidity rates (65). A. Baumannii 
are highly resistant to antibiotics possibly due to presence of drug resistant genes (66).  In this 
study, A. baumannii was responsible for 7% of cases and as in most studies A. baumannii was 
shown to be a highly resistant bacterium to antibiotics. Bacteria such as A. baumannii are difficult 
to treat with Tobramycin being the only agent providing adequate cover against it at 73%. 
In another study done in our centre recently, extra pulmonary tuberculosis infection was shown to 
have a prevalence of 88.6/100 000 population (54).
 Ten cases (5%) were caused by 
Mycobacterium tuberculosis complex in this study and 37% of those Mycobacterium tuberculosis 
complex infections showed mono-resistance to Rifampicin. Further studies are required to 
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investigate prevalence of Mycobacterium tuberculosis complex infections resistance to anti-
tuberculosis drugs used. 
 
The use of serum markers of infection and inflammation in confirming diagnosis of septic 
arthritis has been shown to be unreliable (9). My study shows a slightly different result, of the 33 
patients tested for WCC only 27% had raised WCC. CRP was tested in 13 patients and 12 of the 
13 patients (92%) had abnormal CRP. ESR was tested in 23 patients and in 95% of those patients 
ESR was abnormal. The number of patients who had ESR, CRP and WCC tests done was very 
low, a follow up study might be required to clarify the association between these markers of 
inflammation and confirmed cases of septic arthritis. 
Single surgical debridement was shown to be ineffective in up to 38% of cases in one study. This 
study showed that more than half (55%) of the patients who were surgically treated for septic 
arthritis required re-operation. Submission of new specimen with each episode resulted in 64% of 
a change in the initial bacteria cultured. Indications for re-operation were not objectively 
described in hospital records, further studies analysing clinical response and need for re-operation 
may be useful in future. 
This study may not reflect the true epidemiology of septic arthritis at Chris Hani Baragwanath 
Academic Hospital reasons being, firstly septic arthritis is not a notifiable disease and some 
patients may not be in our records and secondly this retrospective study was dependent on theatre 
records where it was possible that not all patients were recorded. 
Some specimens belonging to patients who were clinically diagnosed with septic arthritis and 
were taken to theatre for arthrotomies were never recorded at the laboratory site and as a result 
this poor record keeping, poor specimens handling and processing may have contributed to losses 
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in patients’ information. Furthermore, there was inconsistency on the number of serological 
investigations and the types of tests done on our patients. 
 
4.1 Future directions 
Future Directions: Given the prevalence and ever-increasing incidence of HIV in our 
communities, further studies can help us understand the relationship between level of immunity 
amongst HIV positive patients that present with septic arthritis looking at their CD4 count, viral 
load, HIV clinical staging, use of antiretroviral and if there is a difference in bacteria cultured. 
The finding of a significant number of patients who had a change in bacteria cultured with 
multiple arthrotomies can be investigated to understand if it correlates with number of days spent 
in hospital and if these were nosocomial infections. 
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Chapter 5 - Conclusion and recommendations. 
 
In this study, gram-positive bacteria were predominant as causative agents of septic arthritis, 
Staphylococcus and Streptococcus spp. accounted for 50% of bacteria that caused septic arthritis. 
Gram negative species accounted for about 40%, although not as common as gram positive 
species they also contribute to causative agents of septic arthritis and they respond to specific and 
unique antibiotics. 
In patients without specific risk factors use of Cloxacillin as the most appropriate antibiotic for 
gram positive cover will only be effective in 30% of the cases, we recommend the use of 
Vancomycin which in our study was shown to have superior cover against gram positive species, 
renal function and general health status of the patients should be continuously monitored 
whenever Vancomycin is used in patients with suspected Streptococcus infection we suggest the 
use of Penicillin or Erythromycin. Newer drugs like Linezolid seem to be superior amongst all 
antibiotics when it comes to gram positive cover but more studies are required before widespread 
use is suggested. In cases of gram negative septic arthritis our study showed that Amikacin and 
Gentamycin had the best sensitivity in the laboratory further studies are needed for clinical 
effectiveness against these bacteria. Bacteria such as A. baumannii are difficult to treat with 
Tobramycin being the only agent providing adequate cover against it. Mycobacterium 
tuberculosis complex should be considered in patients at risk of having TB infection. Treatment 
for TB infection is unique and over a prolonged period. Follow up of results is very important as 
in some cases poly-microbial septic arthritis exists which require multiple antibiotic regimens.  
The importance of frequent bacteriological profiling in each area cannot be over emphasised. 
This study showed a difference in bacteria cultured in our area comparted to other centres. In 
patients who needed multiple debridements it is important to follow up microbiological results as 
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this might change the initial choice of antibiotic or even imply addition of a totally different 
antibiotic. Use of serological test may help in the management of septic arthritis but cannot be 
fully relied onto confirm or dispute the diagnosis. 
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Appendix C – Data Collection Form 
Micro-Organisms causing Septic Arthritis in adult patients 
at Chris Hani Baragwanath Academic Hospital 
Hospital number  
Unique patient code   
Age (years)  
Date of operation  
Organism isolated   
Erythrocyte sedimentation rate (mm/hr)  
C reactive protein (mg/dL)  
Serum white cell count   
 
 
